These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 8353196)

  • 21. Advances in the treatment of arrhythmias: implantable cardioverter-defibrillators.
    Groh WJ; Foreman LD; Zipes DP
    Am Fam Physician; 1998 Jan; 57(2):297-307, 310-2. PubMed ID: 9456993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [From implantable cardioverter-defibrillator to cardiac resynchronization therapy with the use of epicardial left ventricular lead. The evolution of the treatment of post inflammatory heart failure--a case report].
    Gepner K; Sterliński M; Przybylski A; Maciag A; Kołsut P; Szwed H
    Kardiol Pol; 2006 Oct; 64(10):1113-7. PubMed ID: 17089244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First human demonstration of cardiac stimulation with transcutaneous ultrasound energy delivery: implications for wireless pacing with implantable devices.
    Lee KL; Lau CP; Tse HF; Echt DS; Heaven D; Smith W; Hood M
    J Am Coll Cardiol; 2007 Aug; 50(9):877-83. PubMed ID: 17719475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety of nerve conduction studies in patients with implanted cardiac devices.
    Schoeck AP; Mellion ML; Gilchrist JM; Christian FV
    Muscle Nerve; 2007 Apr; 35(4):521-4. PubMed ID: 17094099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Long-term follow-up of pacemaker therapy].
    Lüderitz B
    Z Kardiol; 1990 Jan; 79(1):46-53. PubMed ID: 2180229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inappropriate implantable cardioverter-defibrillator shocks due to temporary epicardial pacing.
    Gelissen M; Debie L; van Opstal J
    Europace; 2010 Nov; 12(11):1648. PubMed ID: 20543194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New generations of implantable pacemaker defibrillators for ventricular and atrial tachyarrhythmias.
    Saksena S; Prakash A; Madan N; Giorgberidze I; Munsif AN; Mathew P; Kaushik R; Krol RB
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():149-54. PubMed ID: 8734177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ventricular pacing lead location alters systemic hemodynamics and left ventricular function in patients with and without reduced ejection fraction.
    Lieberman R; Padeletti L; Schreuder J; Jackson K; Michelucci A; Colella A; Eastman W; Valsecchi S; Hettrick DA
    J Am Coll Cardiol; 2006 Oct; 48(8):1634-41. PubMed ID: 17045900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ventricular pacing threshold variations in the young.
    Silvetti MS; De Santis A; Grovale N; Grutter G; Baccarini A; Drago F
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):175-81. PubMed ID: 17338712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atrial pacing and sensing characteristics in heart failure patients undergoing cardiac resynchronization therapy.
    Schuchert A; Aydin MA; Israel C; Gaby G; Paul V
    Europace; 2005 Mar; 7(2):165-9. PubMed ID: 15763532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experience with a transvenous pacemaker-cardioconverter-defibrillator without subcutaneous patch].
    Gyöngy T; Merkely B; Tenczer J; Vecsey T; Horkay F; Kalmár I; Matkó I; Solti F; Bodor E
    Orv Hetil; 1995 Feb; 136(6):299-304. PubMed ID: 7885681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Atrial defibrillators or implantable atrioverters. Initial results].
    Lévy S; Taramasco V; Corbelli JL; Mistretta R; Dolla E; Ricard P
    Arch Mal Coeur Vaiss; 1998 Jul; 91(7):887-91. PubMed ID: 9749182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Rhythmic pitfalls in cardiac pacing].
    Barnay C; Foltzer E; Tarlet JM; Coste A; Rahal Y; Lasseri C
    Arch Mal Coeur Vaiss; 1998 Mar; 91 Spec No 1():61-9. PubMed ID: 9749286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ventricular capture management in pediatric pacing: efficacy and safety.
    Silvetti MS; De Santis A; Grutter G; Di Ciommo V; Drago F
    Ital Heart J; 2005 Sep; 6(9):751-6. PubMed ID: 16212078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Leadless pacemakers and subcutaneously implantable cardioverter defibrillators].
    Stellbrink C; Hansky B; Meyer Zu Vilsendorf D
    Internist (Berl); 2018 Oct; 59(10):999-1010. PubMed ID: 30105398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of hyperkalaemia on cardiac rhythm devices.
    Barold SS; Herweg B
    Europace; 2014 Apr; 16(4):467-76. PubMed ID: 24465006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of cautery-induced electromagnetic interference of cardiac implantable electrical devices by closely spaced bipolar sensing.
    Suresh M; Benditt DG; Gold B; Joshi GP; Lurie KG
    Anesth Analg; 2011 Jun; 112(6):1358-61. PubMed ID: 21543788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pacemakers, defibrillators, and direct current cardioversion.
    Sgarbossa EB; Black IW; Maloney JD
    Curr Opin Cardiol; 1993 Jan; 8(1):27-38. PubMed ID: 10148086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel mechanism of failure to detect atrial arrhythmias by pacemakers and implantable cardioverter defibrillators.
    Rose E; Chinitz LA; Holmes DS; Aizer A
    J Cardiovasc Electrophysiol; 2010 Mar; 21(3):325-8. PubMed ID: 19682166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcutaneous cardiac pacing in patients with automatic implantable cardioverter defibrillators and epicardial patch electrodes.
    Kemnitz J; Winter J; Vester EG; Peters J
    Anesthesiology; 1992 Aug; 77(2):258-62. PubMed ID: 1642344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.